))
What’s Coming in Device, Cybersecurity, and Digital Health Product Regulation
Manage episode 460958680 series 3622804
内容由Michael Levin-Epstein and FDA Watch提供。所有播客内容（包括剧集、图形和播客描述）均由 Michael Levin-Epstein and FDA Watch 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
In this episode, Shelly and Wayne chat with Neil O’Flaherty, Partner and Head of the Medical Device Practice Group at Amin Wasserman Gurnani LLP, and John Swayer, President of Realistic Quality Solutions, LLC. You’ll hear their thoughts on the top priorities in medical device regulation for the next FDA Commissioner and their insights on laboratory-developed tests, the transition to ISO 13485, cybersecurity guidance and regulation, and digital health product regulation.
In our headlines segment, Shelly and Wayne delve into these major developments:
Pharma: FDA Issues Draft Guidance on Accelerated Approval of Drugs for Serious Conditions
Devices: FDA Publishes Report on Risks and Benefits to Health of Non-Device Software Functions
Food: USDA and FDA Announce Joint Request for Info on Food Date Labeling
Cosmetics: FDA Updates Guidance for Industry on Registration and Listing of Cosmetic Product Facilities and Products
In our Resource Links segment, we listed key documents in our four core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.
Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net.
Music by Dvir Silver from Pixabay.
4集单集
分享
